NewMind's Latest Research Project Challenges Everything You Know About Consciousness & Healing
Discover How Neurofeedback & Ayahuasca Reveal New Paths to Inner Peace
What You'll Learn:
Why neurofeedback could sharpen your focus and ease trauma – Get the science behind brainwave training.
How Ayahuasca appears to offer insights into some people's emotional lives – See real stories of healing from Peru’s Sacred Valley.
The surprising link between ancient rituals and modern tech – Understand how these tools team up for wellness.
Practical insights to rethink your mental health approach – Take away ideas to feel more in control every day.
Join Us for the Whole Journey:
Stream the Full Documentary Now
Step Inside:
Watch, Witness, and Wander the Valley
Crossed Paths Trailer #1
Crossed Paths Trailer #2
Image Gallery - Wander the Valley
Explore the Link Between Neurofeedback and Ayahuasca in Depth with a Podcast
Luke Jensen Discusses How Neurofeedback Boosts Ayahuasca in the Lives Radioshow Podcast
Luke Jensen, primary Ayahuasca researcher and co-producer of the documentary, unpacks the neurofeedback-ayahuasca relationship—how one primes your mind and the other rewires it for sharper clarity and grit. On Lives Radio Show, he bridges jungle brews and qEEG brain map recordings, showing how they team up to reboot your headspace—unlocking focus and peace that stick.
Dive into the Details
Explore Luke Jensen's own comprehensive analysis on the effects of Ayahuasca Ceremony on participants as measured through qEEG on the NewMind Journal:
Get the Latest News
Read exciting news and breaking research in the field of Neurofeedback and Ayahuasca:
Breaking News: “Largest-ever survey on ayahuasca highlights links to better mental health and wellbeing" by Eric W. Dolan on PsyPost, December 12, 2024
Delve into Research
Discover more research on the on neurofeedback and ayahuasa
Peer-Reviewed Study: “Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset" in the Journal of Psychoactive Drugs: Vol 0